Price Schedule: Goods Manufactured Outside the Purchaser’s Country, to be Imported (Group C bids, goods to be imported) Currencies in accordance with ITB 15 Date:_________________________ ICB No: _____________________ Alternative No: ________________ Page N ______ of ______ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Product code Product Strength Dosage form Unit pack Qty. offered Unit prices Total unit Total price per Local agent’s Shipment weight Name of manufac- Ctry. of size [a] CIP named place of (specify one) [b] Inland transp., insurance & other local costs incidental to delivery if specified [c] Other incidental costs as defined in the SCC price [a+b+c] item [6 x 8] as a % of CIP price included in quoted price and volume turer origin Total Bid Price: Currency: In figures: In words: Name of Bidder [insert complete name of Bidder] Signature of Bidder [signature of person signing the Bid] Date [Insert Date] In the capacity of: [ insert: title or other appropriate designation ]
Price Schedule: Goods Manufactured Outside the Purchaser’s Country, already imported* (Group C bids, Goods already imported) Currencies in accordance with ITB 15 Date:_________________________ ICB No: _____________________ Alternative No: ________________ Page N ______ of ______ 1 2 3 4 5 6 7 8 9 10 11 12 13 Product code Product Strength Dosage form Unit pack size Qty. offered Unit prices Total Unit price [c+d+e] Total price per line item [6x8] Sales and other taxes payable per item if Contract is awarded Name of Ctry. of origin standard [a] Unit price Custom Duties and Import Taxes paid and payable [b] Custom Duties and Import Taxes paid and unit [c]=a-b Unit Price net of custom duties and import taxes [d] Inland transp., & other local costs to delivery [e] Other costs as defined in the SCC Note: (i) Column 7[b] Custom Duties and Import Taxes paid should be supported by documentary evidence.. Total Bid Price: Currency: In figures: In words:
This guarantee will expire: (a) if the Applicant is the successful bidder, upon our receipt of copies of the contract agreement signed by the Applicant and the performance security issued to the Beneficiary in relation to such contract agreement; or (b) if the Applicant is not the successful bidder, upon the earlier of (i) our receipt of a copy of the Beneficiary’s notification to the Applicant of the results of the bidding process; or (ii) twenty-eight days after the end of the Bid Validity Period. Consequently, any demand for payment under this guarantee must be received by us at the office indicated above on or before that date. This guarantee is subject to the Uniform Rules for Demand Guarantees (URDG) 2010 Revision, ICC Publication No. 758. _____________________________ [Signature(s)] Note: All italicized text is for use in preparing this form and shall be deleted from the final product. Form of Bid Security (Bid Bond) [The Surety shall fill in this Bid Bond Form in accordance with the instructions indicated.] BOND NO. ______________________ BY THIS BOND [name of Bidder] as Principal (hereinafter called “the Principal”), and [name, legal title, and address of surety], authorized to transact business in [name of country of Purchaser], as Surety (hereinafter called “the Surety”), are held and firmly bound unto [name of Purchaser] as Obligee (hereinafter called “the Purchaser”) in the sum of [amount of Bond] [amount in words], for the payment of which sum, well and truly to be made, we, the said Principal and Surety, bind ourselves, our successors and assigns, jointly and severally, firmly by these presents. WHEREAS the Principal has submitted or will submit a written Bid to the Purchaser dated the ___ day of ______, 20__, for the supply of [name of Contract] (hereinafter called the “Bid”). NOW, THEREFORE, THE CONDITION OF THIS OBLIGATION is such that if the Principal:
1. List of Goods and Delivery Schedule [The Purchaser shall fill in this table, with the exception of the column “Bidder’s offered Delivery date” to be filled by the Bidder] Line Item N Description of Goods Quantity unit Final (Project Site) Destination as specified in BDS Delivery (as per Incoterms) Date Earliest Delivery Date Latest Delivery Date Bidder’s offered Delivery date [to be provided by the bidder] [insert item No] [insert description of Goods] [insert quantity of item to be supplied] [insert physical unit for the [insert place of Delivery] [insert the number of days following the date of effectiveness the Contract] [insert the number of days following the date of effectiveness the Contract] [insert the number of days following the date of effectiveness the Contract]
3. Case Identification 3.1 All cases should prominently indicate the following: Purchaser’s line and code numbers; the generic name of the product; the dosage form (tablet, ampoule, syrup); date of manufacture and expiry (in clear language not code); batch number; quantity per case; special instructions for storage; name and address of manufacture; any additional cautionary statements. 3.2 No case should contain pharmaceutical products from more than one batch. 4. Unique Identifiers 4.1 The Purchaser shall have the right to request the Supplier to imprint a logo, if the quantity so justifies it, on the labels of the containers used for packaging and in certain dosage forms, such as tablets, and ampoules and this will be in the Technical Specifications. The design and detail will be clearly indicated at the time of bidding, and confirmation of the design of such logo shall be provided to the Supplier at the time of contract award. 5. Standards of Quality Control for Supply 5.1 The successful Supplier will be required to furnish to the Purchaser: With each consignment, and for each item a WHO certificate of quality control test results concerning quantitative assay, chemical analysis, sterility, pyrogen content uniformity, microbial limit, and other tests, as applicable to the Goods being supplied and the manufacturer’s certificate of analysis. Assay methodology of any or all tests if requested. Evidence of bio-availability and/or bio-equivalence for certain critical Goods upon request. This information would be supplied on a strictly confidential basis only.
2.2 Type (e.g.: “live attenuated,” “manufactured from purified inactivated (...) obtained from human plasma or manufactured using recombinant DNA technology,” etc.). 2.3 Administration (e.g.: “intended for intramuscular injection,” etc.). 2.4 Description of intended use (e.g.: “immunization of newborn infants,” etc.). 2.5 Dosage size (if not restrictive), or expected immunogenic reaction (e.g.: each dose shall contain that amount of Hbsag protein with micrograms/ml specified by the manufacturer for newborn dosage, that when given as part of a primary immunization series [3 doses] is capable of producing specific humoral antibody [anti HBs] at a level of at least 10 milli international units in >-90 percent of recipients,” etc.). 2.6 Dose package (e.g.: “5 infant dose sterile glass vials,” etc.). 2.7 Filling volume (e.g.: “final product should contain 15% overfill,” etc.). 2.8 Closures (e.g.: “vaccine vials shall be fitted with closures that conform to ISO standard 8362-2”). 2.9 Storage temperature (e.g.: “2–8 degrees C. Do not freeze,” or as appropriate, etc.). 2.10 The product should remain stable up to the indicated test expiry date if kept according to the required storage temperature. 2.11 Standards (e.g.: “The vaccine should conform to standards established by the Purchaser’s country or, where no standard has been adopted, meet current requirements published by the WHO Expert Committee on Biological Standardization, or requirements of an established body of equivalent stature such as the U.S. Pharmacopoeia, the British Pharmacopoeia, the French Pharmacopoeia, or the International Pharmacopoeia”). 3. Labeling Requirements 3.1 Each vial or ampoule shall carry the manufacturer’s standard label in the language of Purchaser’s country, if available at no extra charge; otherwise, the label shall be in English. 3.2 Each vial or ampoule label shall state the following: name of the vaccine;
“Goods” means all of the pharmaceuticals including nutritional supplement and oral and injectable forms of contraception, vaccines, and condoms Supplier is required to supply to the Purchaser under the Contract. “Purchaser’s Country” is the country specified in the Special Conditions of Contract (SCC). “Purchaser” means the entity purchasing the Goods and Related Services, as specified in the SCC. “Registration Certificate” means the certificate of registration or other documents in lieu thereof establishing that the Goods supplied under the Contract are registered for use in the Purchaser’s country in accordance with the Applicable Law. “Related Services” means the services incidental to the supply of the goods, such as insurance, installation, training and initial maintenance and other such obligations of the Supplier under the Contract. “SCC” means the Special Conditions of Contract. “Supplier” means the person, private or government entity, or a combination of the above, whose bid to perform the Contract has been accepted by the Purchaser and is named as such in the Contract Agreement. “The Project Site,” where applicable, means the place named in the SCC. 2. Contract Documents Subject to the order of precedence set forth in the Contract Agreement, all documents forming the Contract (and all parts thereof) are intended to be correlative, complementary, and mutually explanatory. The Contract Agreement shall be read as a whole. 3. Corrupt and Fraudulent Practices 3.1 The Bank requires compliance with its policy in regard to corrupt and fraudulent practices as set forth in Appendix to the GCC. 3.2 The Purchaser requires the Supplier to disclose any commissions or fees that may have been paid or are to be paid to agents or any other party with respect to the bidding process or execution of the Contract. The information disclosed must include at least the name and address of the agent or other party, the amount and currency, and the purpose of the commission, gratuity or fee.